Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Forte Biosciences Price : 76.99 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 01, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 30, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 29, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 28, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 25, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 24, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 23, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 22, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 21, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 18, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 17, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 16, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 15, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 14, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 11, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 10, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 09, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 08, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 04, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 03, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 02, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Sep 01, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Aug 31, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Aug 28, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| argenx SE | 919.21 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
Price Related Metrics
| Price to Book Value | 8.580 |
| Earnings Yield | -6.66% |
| Market Cap | 1.577B |